At Asphalion, we’re dedicating this week to showcasing the importance of Development, Medical & Scientific Writing. Our team of expert consultants can keep you ahead of market challenges and help you meet all regulatory requirements.
Today, we’re putting the spotlight on Paediatric Investigation Plans (PIPs)!
Developing medicines for children requires a dedicated regulatory strategy that ensures paediatric patients have access to safe, effective, and appropriately studied treatments.
At ASPHALION, we support pharmaceutical and biotechnology companies with Development, Medical & Scientific Writing and Regulatory Affairs services throughout the paediatric development pathway. Our expertise includes the preparation of Paediatric Investigation Plans (PIPs), paediatric study documentation, regulatory briefing packages, clinical development documents, and interactions with health authorities.
Explore our carousel to discover how we can support you throughout the PIP process and help navigate paediatric regulatory requirements.
Need help navigating your Regulatory Affairs strategy? Get in touch with us!: [email protected]
Check out our PIP caroussel here: DW week carrousel PIP 2026
Last hours to register to our webinar “Key aspects of biosimilars regulation in Europe, the United States and beyond“: https://bit.ly/4zetQER
Need support with your projects? Contact us at: [email protected]







